IPSU
CAS No. 1373765-19-5
IPSU ( —— )
Catalog No. M23529 CAS No. 1373765-19-5
IPSU is an antagonist of OX2 receptor. IPSU Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 74 | In Stock |
|
5MG | 118 | In Stock |
|
10MG | 151 | In Stock |
|
25MG | 318 | In Stock |
|
50MG | 473 | In Stock |
|
100MG | 683 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIPSU
-
NoteResearch use only, not for human use.
-
Brief DescriptionIPSU is an antagonist of OX2 receptor. IPSU Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors.
-
DescriptionIPSU is an antagonist of OX2 receptor. IPSU Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOX1;OX2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1373765-19-5
-
Formula Weight405.5
-
Molecular FormulaC23H27N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 30 mg/mL (73.98 mM)
-
SMILESCOC1=CC=NC(N(CC2)CCC2(C3=O)CCCN3CC4=CNC5=CC=CC=C54)=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Callander GE, et al. Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptors. Front Neurosci. 2013 Dec 3;7:230.
molnova catalog
related products
-
Pyrroloquinoline qui...
Pyrroloquinoline quinone (PQQ) as a well-known redox enzyme cofactor PQQ?can protect NS/PCs against glutamate toxicity associated with ROS-mediated mitochondrial pathway
-
Bupirimate
Bupirimate, an active ingredient in plant protection products, is commonly used as a systemic fungicide and finds applications in controlling powdery mildew in roses, apple plantations. It belongs to the family of pyrimidines.
-
H-9 hydrochloride
H-9 hydrochloride is a potent and competitive inhibitor of protein kinase C, cAMP-dependent protein kinase, and cGMP.